Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to NVCT. [ FAQ on what and how to ask] For non-NVCT questions, click the logo in the upper-right corner to return to the main page and ask there.
Unlock YouTube Video by Subscribing to iPick.ai Premium!
Not available
Address: 1 Bridge Plaza, 2nd Floor, Suite 275, Fort Lee, NJ, United States, 07024
Employees: 16
Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. The company is developing NXP900, a small molecule drug candidate, which is in Phase 1b clinical trial that inhibits the proto-oncogene c-Src and YES1 kinases for treating solid tumors. The company was formerly known as Centry Pharma, Inc. and changed its name to Nuvectis Pharma, Inc. in July 2021. Nuvectis Pharma, Inc. was incorporated in 2020 and is based in Fort Lee, New Jersey.
Co-Founder, Chairman, CEO & President
Co-Founder, Executive VP, Chief Scientific & Business Officer
Co-Founder, Executive VP, Chief Development & Operations Officer
Vice President of Finance
My Watchlist
